Literature DB >> 13732345

Glucagon as a regulating factor of plasma lipids.

E PALOYAN, P V HARPER.   

Abstract

Entities:  

Keywords:  GLUCAGON/pharmacology; LIPIDS/blood

Mesh：

Substances：

Year:  1961        PMID： 13732345

Source DB:  PubMed          Journal:  Metabolism        ISSN： 0026-0495            Impact factor:   8.694


× No keyword cloud information.
  11 in total

1.  THE EFFECT OF GLUCAGON ON NET SPANCHNIC BALANCES OF GLUCOSE, AMINO ACID NITROGEN, UREA, KETONES, ANS OXYGEN IN MAN.

Authors:  R F KIBLER; W J TAYLOR; J D MYERS
Journal:  J Clin Invest       Date:  1964-05       Impact factor: 14.808

2.  HYPERLIPEMIA ASSOCIATED WITH CHRONIC RELAPSING PANCREATITIS.

Authors:  R B LOWRY; A BOGOCH
Journal:  Can Med Assoc J       Date:  1964-02-08       Impact factor: 8.262

3.  The effect of induced hyperglucagonaemia on the Zucker fatty rat.

Authors:  H A Mahmood; P J Wood; V Marks
Journal:  Diabetologia       Date:  1978-06       Impact factor: 10.122

4.  Hepatic Glucagon Signaling Regulates PCSK9 and Low-Density Lipoprotein Cholesterol.

Authors:  Stefano Spolitu; Haruka Okamoto; Wen Dai; John A Zadroga; Erika S Wittchen; Jesper Gromada; Lale Ozcan
Journal:  Circ Res       Date:  2019-01-04       Impact factor: 17.367

5.  Effect of glucagon on lipid metabolism.

Authors:  G Csapo
Journal:  Experientia       Date:  1964-06-15

6.  The effect of glucagon on pressure and oxygen saturation of splanchnic venous blood.

Authors:  H E Jensen
Journal:  Am J Dig Dis       Date:  1966-06

Review 7.  The metabolic actions of glucagon revisited.

Authors:  Kirk M Habegger; Kristy M Heppner; Nori Geary; Timothy J Bartness; Richard DiMarchi; Matthias H Tschöp
Journal:  Nat Rev Endocrinol       Date:  2010-10-19       Impact factor: 43.330

8.  The effects of triglyceride absorption upon glucagon, insulin, and gut glucagon-like immunoreactivity.

Authors:  I Böttger; R Dobbs; G R Faloona; R H Unger
Journal:  J Clin Invest       Date:  1973-10       Impact factor: 14.808

9.  Stimulation of rat hepatic low density lipoprotein receptors by glucagon. Evidence of a novel regulatory mechanism in vivo.

Authors:  M Rudling; B Angelin
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

10.  Glucagon's Metabolic Action in Health and Disease.

Authors:  Anja Zeigerer; Revathi Sekar; Maximilian Kleinert; Shelly Nason; Kirk M Habegger; Timo D Müller
Journal:  Compr Physiol       Date:  2021-04-01       Impact factor: 9.090
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.